56 related articles for article (PubMed ID: 16182181)
1. Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose.
Stueck AE; Fiel MI
Hum Pathol; 2023 Nov; 141():170-182. PubMed ID: 37541449
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.
Palmer J; Williams K; Inamoto Y; Chai X; Martin PJ; Tomas LS; Cutler C; Weisdorf D; Kurland BF; Carpenter PA; Pidala J; Pavletic SZ; Wood W; Jacobsohn D; Arai S; Arora M; Jagasia M; Vogelsang GB; Lee SJ
Biol Blood Marrow Transplant; 2014 Mar; 20(3):337-44. PubMed ID: 24315845
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria.
Yang AH; Han MAT; Samala N; Rizvi BS; Marchalik R; Etzion O; Wright EC; Cao L; Hakim FT; Jones E; Kapuria D; Hickstein DD; Fowler D; Kanakry JA; Kanakry CG; Kleiner DE; Koh C; Pavletic SZ; Heller T
Transplant Cell Ther; 2022 Nov; 28(11):747.e1-747.e10. PubMed ID: 35878742
[TBL] [Abstract][Full Text] [Related]
4. Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation.
Kim ES; Kwon Y; Choe YH; Kim MJ; Yoo KH
Front Med (Lausanne); 2023; 10():1231066. PubMed ID: 37614955
[TBL] [Abstract][Full Text] [Related]
5. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.
Pidala J; Chai X; Kurland BF; Inamoto Y; Flowers ME; Palmer J; Khera N; Jagasia M; Cutler C; Arora M; Vogelsang G; Lee SJ
Biol Blood Marrow Transplant; 2013 May; 19(5):784-91. PubMed ID: 23395601
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal Biopsies in the Patient Post-Stem Cell Transplant: An Approach to Diagnosis.
Zhang T; Hagen CE
Surg Pathol Clin; 2023 Dec; 16(4):745-753. PubMed ID: 37863563
[TBL] [Abstract][Full Text] [Related]
7. Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?
Alexoudi VA; Gavriilaki E; Cheva A; Sakellari I; Papadopoulou S; Paraskevopoulos K; Vahtsevanos K
Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543084
[TBL] [Abstract][Full Text] [Related]
8. Prediction of histologic alcoholic hepatitis based on clinical presentation limits the need for liver biopsy.
Roth NC; Saberi B; Macklin J; Kanel G; French SW; Govindarajan S; Buzzanco AS; Stolz AA; Donovan JA; Kaplowitz N
Hepatol Commun; 2017 Dec; 1(10):1070-1084. PubMed ID: 29404443
[TBL] [Abstract][Full Text] [Related]
9. Histopathology of graft versus host disease of the liver.
Quaglia A; Duarte R; Patch D; Ngianga-Bakwin K; Dhillon AP
Histopathology; 2007 May; 50(6):727-38. PubMed ID: 17493237
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel histologic diagnostic algorithm for hepatic graft-versus-host disease.
Stueck AE; Schiano TD; Fiel MI
Mod Pathol; 2018 Mar; 31(3):442-451. PubMed ID: 29192646
[TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of deferasirox in pediatric hematopoietic stem cell transplant recipients: one facility's five years' experience of chelation treatment.
Maximova N; Gregori M; Simeone R; Sonzogni A; Boz G; Fucile C; Marini V; Martelli A; Mattioli F
Oncotarget; 2017 Sep; 8(38):63177-63186. PubMed ID: 28968980
[TBL] [Abstract][Full Text] [Related]
12. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.
Shulman HM; Cardona DM; Greenson JK; Hingorani S; Horn T; Huber E; Kreft A; Longerich T; Morton T; Myerson D; Prieto VG; Rosenberg A; Treister N; Washington K; Ziemer M; Pavletic SZ; Lee SJ; Flowers ME; Schultz KR; Jagasia M; Martin PJ; Vogelsang GB; Kleiner DE
Biol Blood Marrow Transplant; 2015 Apr; 21(4):589-603. PubMed ID: 25639770
[TBL] [Abstract][Full Text] [Related]
13. Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation.
Stift J; Baba HA; Huber E; Federmann B; Fischer HP; Schmitt-Graeff A; Baurmann H; Bethge W; Schirmacher P; Wrba F; Greinix H; Fend F; Schwerdtfeger R; Shulman HM; Wolff D; Longerich T;
Virchows Arch; 2014 Feb; 464(2):175-90. PubMed ID: 24385287
[TBL] [Abstract][Full Text] [Related]
14. [Histopathology of graft-versus-host disease].
Länger F; Puls F; Buchholz S; Loddenkemper C; Ganser A; Kreipe H
Pathologe; 2011 Mar; 32(2):144-51. PubMed ID: 21279360
[TBL] [Abstract][Full Text] [Related]
15. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
[TBL] [Abstract][Full Text] [Related]
16. Initial liver involvement in acute GVHD is predictive for nonrelapse mortality.
Robin M; Porcher R; de Castro R; Fisher G; de Latour RP; Ribaud P; Petropoulou AD; Rocha V; Devergie A; Mary JY; Socié G
Transplantation; 2009 Nov; 88(9):1131-6. PubMed ID: 19898210
[TBL] [Abstract][Full Text] [Related]
17. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
18. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
